HomeSYRE • NASDAQ
add
Spyre Therapeutics Inc
Previous close
$32.47
Day range
$32.49 - $34.31
Year range
$10.42 - $47.97
Market cap
1.23B USD
Avg Volume
448.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 4.44M | 45.77% |
Net income | -63.18M | -235.67% |
Net profit margin | — | — |
Earnings per share | -4.05 | 10.00% |
EBITDA | -36.80M | -96.00% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 339.28M | 508.99% |
Total assets | 341.86M | 380.52% |
Total liabilities | 157.84M | 657.44% |
Total equity | 184.02M | — |
Shares outstanding | 36.15M | — |
Price to book | -1.08K | — |
Return on assets | -33.51% | — |
Return on capital | -56.49% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -63.18M | -235.67% |
Cash from operations | -31.04M | -71.09% |
Cash from investing | -35.27M | -351.94% |
Cash from financing | 163.61M | 2,045,175.00% |
Net change in cash | 97.32M | 2,472.40% |
Free cash flow | -18.53M | -66.32% |
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
30
